FDA Inspection 662011 — Sioux Biochemical Inc

Sioux Biochemical Inc — FEI 3000210500

The FDA completed an inspection of Sioux Biochemical Inc on May 19, 2010 in Sioux Center, IA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 15 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 19, 2010
Fiscal Year
2010
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Sioux Center, IA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
141121 CFR 211.105(b)Distinctive ID or code not recorded in batch record
145221 CFR 211.113(b)Validation lacking for sterile drug products
176721 CFR 211.137(a)Expiration date lacking
178721 CFR 211.80(a)Procedures To Be in Writing
188321 CFR 211.165(a)Testing and release for distribution
194321 CFR 211.180(e)(1)Review of representative number of batches
197521 CFR 211.182Written records kept in individual logs
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
432421 CFR 211.110(b)In-process materials specifications testing
436921 CFR 211.188(b)(11)Identification of persons involved, each significant step
437021 CFR 211.188(b)(10)Records of any sampling performed
440421 CFR 211.194(a)(1)Sample identification and other information